FDA · Drug recall
Licorice Coughing Liquid (guaifenesin)…
- Date
- June 1, 2016
- Risk class
- Class I (FDA's definition, 21 CFR 7.3(m): a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death)
- Status
- Terminated
- Filed by
- Master Herbs, Inc./Li
- Product
- Licorice Coughing Liquid (guaifenesin), 5%, 3.38 fl. oz. (100 ml), OTC, Manufactured by: Ma Ying Long Pharmaceutical Group Co., LTD, Wuhan, China; Distributed by: Master Herbs (USA) Inc., NDC 68511-0460-01
- Reason
- Marketed Without An Approved NDA/ANDA: presence of undeclared morphine.
- Distribution pattern
- Nationwide
- Quantity
- 6024 bottles
- Codes and lots
- all lots
- Recall started
- Jan. 15, 2016
- Recall number
- D-0908-2016
What should I do? Medicine recall: what to do
Source: FDA · Drug enforcement report, recall number D-0908-2016. The agency record governs; check it and the company before acting.